These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 6298493

  • 1. [Effect of an oral angiotensin I-converting enzyme inhibitor on blood pressure and renin-angiotensin-aldosterone system before and after nephrectomy in two cases with acute renovascular hypertension].
    Irabu N, Nakamura K, Morohashi Y, Murakami S, Kawamura K.
    Nihon Jinzo Gakkai Shi; 1982 Sep; 24(9):1029-39. PubMed ID: 6298493
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical experience with an oral angiotensin I-converting enzyme inhibitor in hypertensive patients: effects on blood pressure and the renin-aldosterone system by a single dose (author's transl)].
    Mizuno K, Shigetomi S, Haruyama K, Matsui J, Gotho M, Fukuchi S.
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):1-11. PubMed ID: 6247526
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)].
    Shionoiri H, Uneda S, Tochikubo O, Ohonishi T, Harada J, Sesoko S, Goto E, Fujishima S, Kaneko Y.
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):13-22. PubMed ID: 6247528
    [No Abstract] [Full Text] [Related]

  • 7. Effect of aging on the renin angiotensin system in patients with renovascular hypertension.
    Morishita R, Higaki J, Mikami H, Matsukawa N, Ogihara T.
    Methods Find Exp Clin Pharmacol; 1992 Jan; 14(1):17-21. PubMed ID: 1619967
    [Abstract] [Full Text] [Related]

  • 8. Humoral effects of the oral converting-enzyme inhibitor SQ 14,225 in hypertensive patients in supine and tilted position.
    Morganti A, Pickering TG, Lopez-Ovejero J, Laragh JH.
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():149s-152s. PubMed ID: 232018
    [No Abstract] [Full Text] [Related]

  • 9. Contrasting effects of the renin-angiotensin system on renal function disclosed during converting enzyme inhibition in patients with renal hypertension.
    Rasmussen S, Ibsen H, Giese J.
    Scand J Urol Nephrol Suppl; 1984 Dec; 79():49-52. PubMed ID: 6089319
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Inhibition of the angiotensin I converting enzyme with SQ-14225 (captopril) in the medical treatment of severe renovascular hypertension].
    Martínez Amenós A, Caralps A, Rama H, Sarrias X, Alsina J.
    Rev Clin Esp; 1981 Sep 30; 162(6):265-8. PubMed ID: 7036249
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Relationship between vasopressin and the renin-angiotensin-aldosterone system in essential hypertension: effect of converting enzyme inhibitor on plasma vasopressin.
    Santucci A, Leonetti Luparini R, Ferri C, Ficara C, Giarrizzo C, Balsano F.
    J Hypertens Suppl; 1985 Nov 30; 3(2):S133-4. PubMed ID: 3003302
    [Abstract] [Full Text] [Related]

  • 14. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
    Holtzman E, Rosenthal T, Stern N, Knecht A, Yaron A.
    Isr J Med Sci; 1982 May 30; 18(5):597-602. PubMed ID: 6284678
    [Abstract] [Full Text] [Related]

  • 15. Role of aldosterone in experimental hypertension.
    McCaa RE, McCaa CS, Bengis RG, Guyton AC.
    J Endocrinol; 1979 May 30; 81(2):69P-78P. PubMed ID: 222873
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of angiotensin I converting enzyme inhibitor (captopril) on blood pressure and bradykinin in patients with excessive aldosterone secretion].
    Haruyama K, Mizuno K, Yamazaki M, Toki T, Yaginuma K, Fukuchi S.
    Nihon Jinzo Gakkai Shi; 1984 Apr 30; 26(4):437-44. PubMed ID: 6381834
    [No Abstract] [Full Text] [Related]

  • 17. [Antihypertensive effect of the oral angiotensin I-converting enzyme inhibitor in long-term treatment of hypertensive patients (author's transl)].
    Mizuno K, Gotoh M, Shigetomi S, Matsui J, Tsutsui K, Ogata M, Fukuchi S.
    Nihon Jinzo Gakkai Shi; 1981 Aug 30; 23(8):1113-21. PubMed ID: 7033606
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of captopril on blood pressure and renin-angiotensin-aldosterone system in hypertensive subjects after inhibition of renal vasodilative system.
    Santucci A, Aguglia F, De Mattia G, Cammarella I, Giordano M, Gnecchi M, Trinchieri F, Ficara C.
    Int J Clin Pharmacol Res; 1984 Aug 30; 4(1):41-5. PubMed ID: 6381343
    [Abstract] [Full Text] [Related]

  • 20. Study of renovascular hypertension in rat. II. Effects of converting enzyme inhibitor (captopril) in the acute and chronic stages of two-kidney one-clip Goldblatt hypertension in rat.
    Matsushita K.
    Tokai J Exp Clin Med; 1985 Apr 30; 10(1):31-6. PubMed ID: 3913058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.